InflaRx (IFRX) Treasury Shares (2016 - 2018)

InflaRx's (IFRX) quarterly Treasury Shares came in at -$57069.8 in Q4 2018, down 115.1% quarter-over-quarter from $377903.5 in Q4 2016.

InflaRx (IFRX) Treasury Shares (2016 - 2018) Analysis & Trends

InflaRx has disclosed Treasury Shares across 2 years of filings, most recently posting -$57069.8 for Q4 2018.

Treasury Shares for Q4 2018 came in at -$57069.8, changed N/A year-over-year; the trailing twelve-month figure through Dec 2018 was -$57069.8 (changed N/A YoY), and the FY2018 annual result was -$57069.8, changed N/A from the prior year.
Treasury Shares came in at -$57069.8 for Q4 2018 at InflaRx, down from $377903.5 in the prior quarter.
In the past five years, Treasury Shares ranged from a high of $377903.5 in Q4 2016 to a low of -$57069.8 in Q4 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Alterity Therapeutics	723,416.35 Bn	723,416.32 Bn	-	-
2	Belite Bio	57,340.00 Bn	57,340.00 Bn	-	-
3	Quantum Biopharma	19,125.08 Bn	19,125.08 Bn	-	-
4	Legend Biotech	3,262.00 Bn	3,261.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,789.67 Bn	1,789.67 Bn	-	-
6	Evaxion A	1,480.39 Bn	1,480.37 Bn	-	-
7	Psyence Biomedical	241.78 Bn	241.78 Bn	-	1.48 Mn
8	Vertex Pharmaceuticals	113.54 Bn	106.29 Bn	2.59 Bn	700,000.00
9	Abivax	94.26 Bn	94.26 Bn	-	-
10	InflaRx	764.68 Mn	764.68 Mn	10,877.40	-

Download Data